U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07067099) titled 'Neutralizing Interferon Type 1 in Hidradenitis Suppurativa' on July 04.
Brief Summary: The purpose of the study is to evaluate the safety and type 1 Interferon (IFN) neutralization in patients with refractory severe Hidradenitis Suppurativa (Hurley stage III) after transfusion of plasma containing high titer anti-IFN-1 autoantibodies.
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Hidradenitis Suppurativa (HS)
Intervention:
BIOLOGICAL: Plasma with neutralizing autoantibodies to Type I Interferons
Transfusion of one unit of plasma containing high titre anti-IFN-1 autoantibodies
Recruitment Status: NOT_YET...